ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 312 out of 6645

$1.21M Total Retail Price of All Prescriptions

Rank: 220 out of 6645

364 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 13,355 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,157 1,007 1 1
CARVEDILOL 471 447 2 25
GLIMEPIRIDE 380 353 3 47
AMLODIPINE BESYLATE 379 354 4 2
OMEPRAZOLE 338 278 5 6
METFORMIN HCL 328 265 6 7
LOSARTAN POTASSIUM 310 276 7 12
MELOXICAM 310 252 7 46
LOSARTAN-HYDROCHLOROTHIAZIDE 292 246 9 62
GABAPENTIN 287 246 10 18
ALENDRONATE SODIUM 287 283 10 14
ACTOPLUS MET 271 237 10 12 275
TAMSULOSIN HCL 256 216 13 22
JANUVIA 248 246 14 38
NEXIUM 245 244 15 40
ADVAIR DISKUS 229 206 16 45
DIOVAN 228 218 17 19
LISINOPRIL 225 178 18 3
PATANOL 222 195 19 131
HYDROCHLOROTHIAZIDE 219 165 20 9
ACTOS 201 200 21 71
FUROSEMIDE 180 134 22 11
AMLODIPINE BESYLATE-BENAZEPRIL 175 165 23 97
SINGULAIR 173 167 24 76
FLUTICASONE PROPIONATE 168 113 25 26
ATORVASTATIN CALCIUM 166 153 26 10
SYMBICORT 165 146 27 153
BETAMETHASONE DIPROPIONATE 157 138 28 289
FINASTERIDE 157 143 28 73
RAMIPRIL 151 110 30 118
AVODART 139 130 31 99
DIOVAN HCT 136 133 32 64
NABUMETONE 136 120 32 190
TRAMADOL HCL 134 89 34 30
ACARBOSE 134 131 34 211
CRESTOR 127 119 36 34
LEVOTHYROXINE SODIUM 126 86 37 4
METOCLOPRAMIDE HCL 124 108 38 120
ZETIA 123 110 39 87
DONEPEZIL HCL 121 121 40 27
BENAZEPRIL HCL 119 107 41 21
TERAZOSIN HCL 117 101 42 48
ALLOPURINOL 113 103 43 31
SPIRONOLACTONE 110 101 44 85
MEGESTROL ACETATE 109 108 R 45 104
CELEBREX 104 104 46 54
METOPROLOL TARTRATE 104 74 46 13
CILOSTAZOL 102 89 48 202
VYTORIN 92 91 49 170
VESICARE 91 91 50 148
SPIRIVA 91 66 50 65
ONGLYZA 86 70 52 168
OXYBUTYNIN CHLORIDE ER 82 80 53 179
MUPIROCIN 79 66 54 294
PANTOPRAZOLE SODIUM 76 75 55 29
PIOGLITAZONE HCL 75 70 R 56 184
PIOGLITAZONE-METFORMIN 74 69 R 57 467
COREG CR 74 53 57 242
MIRTAZAPINE 70 62 59 70
DIPHENOXYLATE-ATROPINE 69 62 60 214
CIPROFLOXACIN HCL 64 52 61 67
CARBIDOPA-LEVODOPA 64 53 61 116
PROAIR HFA 63 34 63 32
ALBUTEROL SULFATE 63 61 63 112
LIDODERM 61 61 65 53
CLOPIDOGREL 59 58 66 36
LIPITOR 59 59 66 69
FELODIPINE ER 58 58 68 105
CEPHALEXIN 57 40 69 111
MONTELUKAST SODIUM 56 49 70 128
BENICAR 56 55 70 84
DEXILANT 56 55 70 102
WARFARIN SODIUM 51 36 73 16
PHENYTOIN SODIUM EXTENDED 51 39 73 172
PLAVIX 51 49 73 49
AMITRIPTYLINE HCL 50 49 R 76 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.